Clinical Trials at Edward Hospital/Cancer Center
As of August 2026, 18 paid clinical trials are recruiting at Edward Hospital/Cancer Center, located at 1220 HOBSON RD, SUITE 124, NAPERVILLE, IL 60540-8139, phone (630) 527-3200 in Naperville, Illinois. Active studies at this site cover conditions such as Heart Failure, Bipolar Disorder and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
18 clinical trials at Edward Hospital/Cancer Center
·Clear filters·Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
E-Mindfulness Approaches for Living After Breast Cancer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Common conditions studied in Naperville
- Heart Failure (10 active studies)
- Bipolar Disorder (2 active studies)
- Breast Cancer (2 active studies)
- Heart Failure With Reduced Ejection Fraction (2 active studies)
- Metastatic Renal Cell Carcinoma (2 active studies)
- Migraine (2 active studies)
Leading research sponsors in Naperville
- NRG Oncology
- National Cancer Institute (NCI)
- Pfizer
- Alleviant Medical, Inc.
- Colorado Prevention Center
Frequently asked questions
How many paid clinical trials are currently recruiting in Naperville?
There are approximately 64 recruiting clinical trials in Naperville, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Naperville pay participants?
Most recruiting trials in Naperville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Naperville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Naperville?
The most common conditions under active study in Naperville include Heart Failure (10), Bipolar Disorder (2), Breast Cancer (2), Heart Failure With Reduced Ejection Fraction (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Naperville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Naperville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Naperville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Naperville?
Recruiting research sites in Naperville include Edward Hospital/Cancer Center, Midwest Cardiovascular Institute, Baber Research Group, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Naperville right now?
The largest active categories in Naperville are Cancer & tumors (21), Cardiovascular (14), Neurology & pain (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Edward Hospital/Cancer Center?
Edward Hospital/Cancer Center is located at 1220 HOBSON RD, SUITE 124, NAPERVILLE, IL 60540-8139. Use the Google Maps link in the intro above to get directions.
How do I contact Edward Hospital/Cancer Center?
You can reach Edward Hospital/Cancer Center by phone at (630) 527-3200. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.